Terms: = Pancreatic cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1
617 results:
1. PRaG 3.0 therapy for human epidermal growth factor receptor 2-positive metastatic pancreatic ductal adenocarcinoma: A case report.
Kong YH; Xu ML; Zhang JJ; Chen GQ; Hong ZH; Zhang H; Dai XX; Ma YF; Zhao XR; Zhang CY; Chen RZ; Xing PF; Zhang LY
World J Gastroenterol; 2024 Mar; 30(9):1237-1249. PubMed ID: 38577174
[TBL] [Abstract] [Full Text] [Related]
2. Circulating tumor-associated antigen-specific IFNγ
Murakami H; Takahama S; Akita H; Kobayashi S; Masuta Y; Nagatsuka Y; Higashiguchi M; Tomokuni A; Yoshida K; Takahashi H; Doki Y; Eguchi H; Matsuura N; Yamamoto T
Front Immunol; 2024; 15():1363568. PubMed ID: 38550601
[TBL] [Abstract] [Full Text] [Related]
3. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
4. A Comparison of Spatial and Phenotypic Immune Profiles of pancreatic Ductal Adenocarcinoma and Its Precursor Lesions.
Enzler T; Shi J; McGue J; Griffith BD; Sun L; Sahai V; Nathan H; Frankel TL
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474199
[TBL] [Abstract] [Full Text] [Related]
5. Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models.
Nakazawa Y; Miyano M; Tsukamoto S; Kogai H; Yamamoto A; Iso K; Inoue S; Yamane Y; Yabe Y; Umihara H; Taguchi J; Akagi T; Yamaguchi A; Koga M; Toshimitsu K; Hirayama T; Mukai Y; Machinaga A
Nat Commun; 2024 Mar; 15(1):2192. PubMed ID: 38467634
[TBL] [Abstract] [Full Text] [Related]
6. 4-Hydroxyphenylpyruvate Dioxygenase-Like predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis.
Li H; Liu J; Wang S; Xu Y; Tang Q; Ying G
Aging (Albany NY); 2024 Mar; 16(5):4327-4347. PubMed ID: 38451188
[TBL] [Abstract] [Full Text] [Related]
7. Coxsackievirus infection induces direct pancreatic β cell killing but poor antiviral CD8
Vecchio F; Carré A; Korenkov D; Zhou Z; Apaolaza P; Tuomela S; Burgos-Morales O; Snowhite I; Perez-Hernandez J; Brandao B; Afonso G; Halliez C; Kaddis J; Kent SC; Nakayama M; Richardson SJ; Vinh J; Verdier Y; Laiho J; Scharfmann R; Solimena M; Marinicova Z; Bismuth E; Lucidarme N; Sanchez J; Bustamante C; Gomez P; Buus S; ; You S; Pugliese A; Hyoty H; Rodriguez-Calvo T; Flodstrom-Tullberg M; Mallone R
Sci Adv; 2024 Mar; 10(10):eadl1122. PubMed ID: 38446892
[TBL] [Abstract] [Full Text] [Related]
8. Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma.
Liang Y; Zhong D; Zhang Z; Su Y; Yan S; Lai C; Yao Y; Shi Y; Huang X; Shang J
BMC Cancer; 2024 Mar; 24(1):291. PubMed ID: 38438842
[TBL] [Abstract] [Full Text] [Related]
9. Mechanism exploration of Zoledronic acid combined with pd-1 in the treatment of hepatocellular carcinoma.
Fan X; Yan Z; Lin Y; Wang Q; Jiang L; Yao X; Dong L; Chen L; Zhao T; Zhao J; Hu H; Wang H
Cancer Immunol Immunother; 2024 Mar; 73(4):62. PubMed ID: 38430249
[TBL] [Abstract] [Full Text] [Related]
10. Case report: Diverse immune responses in advanced pancreatic ductal adenocarcinoma treated with immune checkpoint inhibitor-based conversion therapies.
Li X; Xiao C; Li R; Zhang P; Yang H; Cao D
Front Immunol; 2024; 15():1326556. PubMed ID: 38415262
[TBL] [Abstract] [Full Text] [Related]
11. Radiation-Activated Resiquimod Prodrug Nanomaterials for Enhancing Immune Checkpoint Inhibitor Therapy.
Sun J; Yao H; Ren X; Cui L; Liu L; Wang G; Tang Z
Nano Lett; 2024 Mar; 24(9):2921-2930. PubMed ID: 38411094
[TBL] [Abstract] [Full Text] [Related]
12. A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way.
Balar PC; Apostolopoulos V; Chavda VP
Eur J Pharmacol; 2024 Apr; 969():176451. PubMed ID: 38408598
[TBL] [Abstract] [Full Text] [Related]
13. pd-1 regulation in immune homeostasis and immunotherapy.
Gao M; Shi J; Xiao X; Yao Y; Chen X; Wang B; Zhang J
Cancer Lett; 2024 Apr; 588():216726. PubMed ID: 38401888
[TBL] [Abstract] [Full Text] [Related]
14. Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysis.
Chen Y; Zhang F; Zhang B; Trojanowicz B; Hämmerle M; Kleeff J; Sunami Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1990. PubMed ID: 38389400
[TBL] [Abstract] [Full Text] [Related]
15. Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization.
Xu W; Weng J; Xu M; Zhou Q; Liu S; Hu Z; Ren N; Zhou C; Shen Y
Cancer Immunol Immunother; 2024 Feb; 73(3):56. PubMed ID: 38367070
[TBL] [Abstract] [Full Text] [Related]
16. Characterization of lymphocyte-rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures.
Ahn B; Ahn HS; Shin J; Jun E; Koh EY; Ryu YM; Kim SY; Sung CO; Shim JH; Hong J; Kim K; Kang HJ
Liver Int; 2024 May; 44(5):1202-1218. PubMed ID: 38363048
[TBL] [Abstract] [Full Text] [Related]
17. BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma.
Yu Z; Wu X; Zhu J; Yan H; Li Y; Zhang H; Zhong Y; Lin M; Ye G; Li X; Jin J; Li K; Wang J; Zhuang H; Lin T; He J; Lu C; Xu Z; Zhang X; Li H; Jin X
Cell Mol Life Sci; 2024 Feb; 81(1):82. PubMed ID: 38340178
[TBL] [Abstract] [Full Text] [Related]
18. Exhausted Tumor-infiltrating CD39+CD103+ CD8+ T Cells Unveil Potential for Increased Survival in Human pancreatic cancer.
Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
Cancer Res Commun; 2024 Feb; 4(2):460-474. PubMed ID: 38335302
[TBL] [Abstract] [Full Text] [Related]
19. "RIPping" off Pancreas cancer's Blockage of Immune Surveillance.
Liu X; Sells BE; DeNardo DG
Cancer Discov; 2024 Feb; 14(2):208-210. PubMed ID: 38327192
[TBL] [Abstract] [Full Text] [Related]
20. Effect of transcatheter arterial chemoembolization combined with lenvatinib plus anti-pd-1 antibodies in patients with unresectable hepatocellular carcinoma: A treatment with Chinese characteristics.
Wu J; Wu J; Li S; Luo M; Zeng Z; Li Y; Fu Y; Li H; Liu D; Ou X; Lin Z; Wei S; Yan M
Biosci Trends; 2024 Mar; 18(1):42-48. PubMed ID: 38325823
[TBL] [Abstract] [Full Text] [Related]
[Next]
